NCT03987139

Brief Summary

The purpose is, in patients with aneurysmal subarachnoid haemorrhage in the early phase after ictus, to examine the following:

  1. 1.The effect of spontaneous and induced changes on the brain's static and dynamic autoregulation calculated by transcranial Doppler (TCD), ICP and MAP (primary purposes) and ICP and PbtO2;
  2. 2.The effect of mild hyper- and hypocapnia as well as of mild hyper- and hypoxia on the brain's static and dynamic autoregulation, ICP and PbtO2;
  3. 3.The relationship between brain autoregulation, mild hyper- and hypocapnia, as well as of mild hyper- and hypoxia and metabolism in microdialysate on the one hand and the occurrence of DCI during hospitalization and poor neurological outcome one year after ictus on the other.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 14, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

June 15, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

October 29, 2021

Status Verified

October 1, 2021

Enrollment Period

2.3 years

First QC Date

June 11, 2019

Last Update Submit

October 22, 2021

Conditions

Keywords

cerebral autoregulation

Outcome Measures

Primary Outcomes (1)

  • Middle cerebral artery flow velocity (MCAv) + induced hypertension

    Measuring MCAv after induced hypertension

    within 5 days after ictus, for 10 minutes after steady state

Secondary Outcomes (6)

  • Intracranial pressure (ICP) + induced hypertension

    within 5 days after ictus

  • Partial brain tissue oxygenation (PbtO2) + induced hypertension

    within 5 days after ictus

  • Intracranial pressure (ICP) + hyper- and hypocapnia

    within 5 days after ictus, for 10 minutes after steady state

  • Partial brain tissue oxygenation (PbtO2) + hyper- and hypocapnia

    within 5 days after ictus, for 10 minutes after steady state

  • Intracranial pressure (ICP) + hyper- and hypoxia

    within 5 days after ictus, for 10 minutes after steady state

  • +1 more secondary outcomes

Study Arms (1)

All patients

OTHER

Patients included in the study.

Other: HypertensionOther: Hyper- and hypoxiaOther: Hyper- and hypocapnia

Interventions

Hypertension is induced by an infusion of noradrenaline within acceptable limits Baseline recording (10 minutes) is performed. MAP gradually increases in steps of 5-10 mmHg during ongoing TCD. When the desired maximum MAP is reached, measurement is made at steady state (10 minutes). Noradrenaline infusion is stopped. When MAP is stabilized, new baseline is measured for 10 minutes.

All patients

The mechanical ventilator is adjusted to mild hypoxia, normoxia and mild hyperoxia. Measurements are made for 10 minutes at normoxia and after steady state is reached, respectively. hyperoxia and hypoxia. Oxygenation is controlled by arterial blood gas before and during steady state.

All patients

The mechanical ventilator is adjusted to a delta PaCO2 on the ventilator for both hypocapnia and hypercapnia. Measurements are made for 10 minutes at normocapnia and after steady state is reached, respectively. hyper- and hypocapnia.

All patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admittance to neurointensive care unit, Rigshospitalet
  • Age ≥ 18 years old
  • Aneurysmal subarachnoid haemorrhage
  • Clinical indication for placement of an external ventricular drain
  • Measurements can be done within 3 days of ictus
  • Closest relatives understand written and spoken danish

You may not qualify if:

  • No aneurysm identified
  • Conservative og failed treatment of aneurysm
  • Pupils dilated and do not react to light
  • Expected death within 48 hours
  • Acute or chronic diseases associated with impaired autoregulation
  • Severe chronic lung failure with a PaCO2 \> 6.5 kPa or PaO2 \< 8 kPa.
  • Age ≥ 18 years old;
  • Understands written and spoken danish
  • Oral and written consent
  • No medication expect hay fever medications
  • Alcohol consumption within the limits from the danish health care board
  • Healthy without previous or current cerebrovascular diseases
  • Insonation is possible from the middle cerebral artery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neuroanaesthesiology

Copenhagen, Capital Region, 2200, Denmark

Location

Related Publications (23)

  • Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen HJ, Hoffmann GF, Jardine P, von Moers A, Mordekar SR, O'Callaghan F, Wassmer E, Wraige E, Dietrich C, Lewis T, Hyland K, Heales S Jr, Sanger T, Gissen P, Assmann BE, Reith ME, Maher ER. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 2011 Jan;10(1):54-62. doi: 10.1016/S1474-4422(10)70269-6. Epub 2010 Nov 25.

    PMID: 21112253BACKGROUND
  • Olsen MH, Orre M, Leisner ACW, Rasmussen R, Bache S, Welling KL, Eskesen V, Moller K. Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: Functional outcome and long-term mortality. Acta Anaesthesiol Scand. 2019 Oct;63(9):1191-1199. doi: 10.1111/aas.13412. Epub 2019 Jun 7.

    PMID: 31173342BACKGROUND
  • van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007 Jan 27;369(9558):306-18. doi: 10.1016/S0140-6736(07)60153-6.

    PMID: 17258671BACKGROUND
  • Brathwaite S, Macdonald RL. Current management of delayed cerebral ischemia: update from results of recent clinical trials. Transl Stroke Res. 2014 Apr;5(2):207-26. doi: 10.1007/s12975-013-0316-8. Epub 2013 Dec 13.

    PMID: 24338266BACKGROUND
  • Schmidt JM, Wartenberg KE, Fernandez A, Claassen J, Rincon F, Ostapkovich ND, Badjatia N, Parra A, Connolly ES, Mayer SA. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg. 2008 Dec;109(6):1052-9. doi: 10.3171/JNS.2008.109.12.1052.

    PMID: 19035719BACKGROUND
  • Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23. doi: 10.1186/cc8886. Epub 2010 Feb 22.

    PMID: 20175912BACKGROUND
  • Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):337-41. doi: 10.1136/jnnp.68.3.337.

    PMID: 10675216BACKGROUND
  • Dorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol. 2012 Apr;259(4):679-83. doi: 10.1007/s00415-011-6243-2. Epub 2011 Sep 24.

    PMID: 21947244BACKGROUND
  • Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013 Mar;9(3):152-63. doi: 10.1038/nrneurol.2013.11. Epub 2013 Feb 19.

    PMID: 23419369BACKGROUND
  • Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014 Jan;10(1):44-58. doi: 10.1038/nrneurol.2013.246. Epub 2013 Dec 10.

    PMID: 24323051BACKGROUND
  • LASSEN NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959 Apr;39(2):183-238. doi: 10.1152/physrev.1959.39.2.183. No abstract available.

    PMID: 13645234BACKGROUND
  • Berg, R.M.G., Pedersen, M., Møller, K.: Static cerebral blood flow autoregulation in humans. Curr. Hypertens. Rev. 5, 140-157 (2009).

    BACKGROUND
  • Czosnyka M, Smielewski P, Piechnik S, Steiner LA, Pickard JD. Cerebral autoregulation following head injury. J Neurosurg. 2001 Nov;95(5):756-63. doi: 10.3171/jns.2001.95.5.0756.

    PMID: 11702864BACKGROUND
  • Eames PJ, Blake MJ, Dawson SL, Panerai RB, Potter JF. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):467-72. doi: 10.1136/jnnp.72.4.467.

    PMID: 11909905BACKGROUND
  • Strauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol. 1998 Feb;28(2):199-203. doi: 10.1016/0168-8278(88)80006-0.

    PMID: 9514532BACKGROUND
  • Moller K, Skinhoj P, Knudsen GM, Larsen FS. Effect of short-term hyperventilation on cerebral blood flow autoregulation in patients with acute bacterial meningitis. Stroke. 2000 May;31(5):1116-22. doi: 10.1161/01.str.31.5.1116.

    PMID: 10797174BACKGROUND
  • Otite F, Mink S, Tan CO, Puri A, Zamani AA, Mehregan A, Chou S, Orzell S, Purkayastha S, Du R, Sorond FA. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke. 2014 Mar;45(3):677-82. doi: 10.1161/STROKEAHA.113.002630. Epub 2014 Jan 14.

    PMID: 24425120BACKGROUND
  • Budohoski KP, Czosnyka M, Kirkpatrick PJ, Reinhard M, Varsos GV, Kasprowicz M, Zabek M, Pickard JD, Smielewski P. Bilateral failure of cerebral autoregulation is related to unfavorable outcome after subarachnoid hemorrhage. Neurocrit Care. 2015 Feb;22(1):65-73. doi: 10.1007/s12028-014-0032-6.

    PMID: 25056137BACKGROUND
  • Ma X, Willumsen L, Hauerberg J, Pedersen DB, Juhler M. Effects of graded hyperventilation on cerebral blood flow autoregulation in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2000 Apr;20(4):718-25. doi: 10.1097/00004647-200004000-00009.

    PMID: 10779016BACKGROUND
  • Ramakrishna R, Stiefel M, Udoetuk J, Spiotta A, Levine JM, Kofke WA, Zager E, Yang W, Leroux P. Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008 Dec;109(6):1075-82. doi: 10.3171/JNS.2008.109.12.1075.

    PMID: 19035722BACKGROUND
  • Skjoth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004 Jan;100(1):8-15. doi: 10.3171/jns.2004.100.1.0008.

    PMID: 14743906BACKGROUND
  • Roh DJ, Morris NA, Claassen J. Intracranial Multimodality Monitoring for Delayed Cerebral Ischemia. J Clin Neurophysiol. 2016 Jun;33(3):241-9. doi: 10.1097/WNP.0000000000000277.

    PMID: 27258448BACKGROUND
  • Olsen MH, Capion T, Riberholt CG, Bache S, Ebdrup SR, Rasmussen R, Mathiesen T, Berg RMG, Moller K. Effect of controlled blood pressure increase on cerebral blood flow velocity and oxygenation in patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand. 2023 Sep;67(8):1054-1060. doi: 10.1111/aas.14277. Epub 2023 May 16.

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Model Details: Intervention is performed once in both patients (after the aneurysm is closed and max. 5 days after ictus) and controls. The procedure consists of the following sessions: 1. Induced hypertension; as well 2. (Only in mechanically ventilated patients) either 1. Mild hyper- and hypocapnia or 2. Mild hyper- and hypoxia. In session 2 (hyper- / hypoxia or hyper- / hypocapnia), patients are randomized to order the interventions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Fellow

Study Record Dates

First Submitted

June 11, 2019

First Posted

June 14, 2019

Study Start

June 15, 2019

Primary Completion

October 1, 2021

Study Completion

March 1, 2022

Last Updated

October 29, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

Data from each individual participant will be available after publication of planned manuscripts, with a valid reason, and after signing a data processing agreement.

Shared Documents
STUDY PROTOCOL
Time Frame
The approved study protocol will be available upon request until publication of the study results
Access Criteria
Valid reason and contact with author

Locations